IOX2, ML324, KDMOAM25, succinate,
fumarate, 2OG, dimethylpyridine-2,4-dicarboxylate, dimethyl 2-oxoglutarate,
dimethyl succinate, dimethyl fumarate, and DMOG were purchased from
Sigma-Aldrich, while IOX3, IOX4, Roxadustat, Vadadustat, Panobinostat,
disodium 2S/2R-hydroxyglutarate, and FG0041 were
obtained from Cayman Chemical Company. 2,4-PDCA (Alfa Aesar), Daprodustat
(MedChemExpress), QC6352 (MedChemExpress), Molidustat (Selleck Chem),
JIB-04 (Tocris Bioscience), GSK-J1 (Tocris Bioscience), GSK-J4 (Tocris
Bioscience), SD70 (Xcess Biosciences), CPI455 (Axon Med Chem), 2′-deoxy-5-methylcytidine
(TCI Chemicals), 2′-deoxy-5-(hydroxymethyl)cytidine (TCI Chemicals),
and (R/S)-Octyl-α-hydroxyglutarate
(Cambridge Bioscience) were purchased from other commercial sources.
All purchased inhibitors were >95% pure as determined by the manufacturer.
Key compound purity was verified using analytical HPLC using a UV
detector (210 or 254 nm) or CAD detector (
and methods and has a purity >95% as determined by HPLC. All buffer
components were from Sigma-Aldrich unless otherwise stated.